Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms-Reference-Cited by-同舟云学术

Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms

Published:2014-10-03 Issue:10 Volume:193 Page:4823-4832
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Chen Ding,Blazek Monica,Ireland Sara,Ortega Sterling,Kong Xiangmei,Meeuwissen Anouk,Stowe Ann,Carter Laura,Wang Yue,Herbst Ronald,Monson Nancy L.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Multiple Sclerosis — The Plaque and Its Pathogenesis

2. Potential impact of B cells on T cell function in multiple sclerosis.;Ireland;Mult. Scler. Int.,2011

3. The role of antibodies in multiple sclerosis.;Weber;Biochim. Biophys. Acta,2011

4. B cells and antibodies in multiple sclerosis pathogenesis and therapy

5. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects;Pharmacological Reports;2024-08-23

2. CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity;Neurology Neuroimmunology & Neuroinflammation;2023-03

3. Monoclonal antibodies in multiple sclerosis treatment;Translational Neuroimmunology, Volume 8;2023

4. Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy;Acta Neuropathologica Communications;2022-10-28

5. Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy;2022-07-24